TY  - GEN
AU  - Slaton,J W
AU  - Karashima,T
AU  - Perrotte,P
AU  - Inoue,K
AU  - Kim,S J
AU  - Izawa,J
AU  - Kedar,D
AU  - McConkey,D J
AU  - Millikan,R
AU  - Sweeney,P
AU  - Yoshikawa,C
AU  - Shuin,T
AU  - Dinney,C P
TI  - Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder
SN  - 1078-0432
PY  - 2001///1004
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Antineoplastic Agents, Phytogenic
KW  - therapeutic use
KW  - Biopsy
KW  - Blood Vessels
KW  - drug effects
KW  - Blotting, Northern
KW  - Cadherins
KW  - analysis
KW  - Carcinoma, Transitional Cell
KW  - drug therapy
KW  - Cell Movement
KW  - Collagen
KW  - Collagenases
KW  - Dose-Response Relationship, Drug
KW  - Drug Combinations
KW  - Drug Synergism
KW  - Endothelial Growth Factors
KW  - genetics
KW  - Female
KW  - Fibroblast Growth Factor 2
KW  - Follow-Up Studies
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - In Situ Hybridization
KW  - Interferon-alpha
KW  - Interleukin-8
KW  - Laminin
KW  - Lymphokines
KW  - Male
KW  - Matrix Metalloproteinase 9
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Neoplasm Metastasis
KW  - pathology
KW  - Neoplasm Staging
KW  - Neovascularization, Pathologic
KW  - prevention & control
KW  - Paclitaxel
KW  - Prognosis
KW  - Proteoglycans
KW  - RNA, Messenger
KW  - Tumor Cells, Cultured
KW  - Urinary Bladder
KW  - chemistry
KW  - Urinary Bladder Neoplasms
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factors
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S
ER  -